Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Cash Flow Reinvestment Rate
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting CN¥26.90 Million (capex CN¥26.90 Million ) from operating cash flow of CN¥133.43 Million. Check 600572 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Explore Zhejiang CONBA Pharmaceutical Co Ltd (600572) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Zhejiang CONBA Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market value of Zhejiang CONBA Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥203.16 Million | CN¥942.61 Million | CN¥147.26 Million | ▼ -37.5% |
| 2024 | 0.34x | CN¥349.14 Million | CN¥1.01 Billion | CN¥290.63 Million | ▼ -9.3% |
| 2023 | 0.38x | CN¥341.77 Million | CN¥898.64 Million | CN¥209.14 Million | ▲ +13.9% |
| 2022 | 0.33x | CN¥385.99 Million | CN¥1.16 Billion | CN¥291.75 Million | ▼ -59.7% |
| 2021 | 0.83x | CN¥736.86 Million | CN¥889.94 Million | CN¥568.37 Million | ▲ +40.6% |
| 2020 | 0.59x | CN¥736.05 Million | CN¥1.25 Billion | CN¥460.40 Million | ▲ +19.8% |
| 2019 | 0.49x | CN¥454.84 Million | CN¥925.50 Million | CN¥268.79 Million | ▼ -83.6% |
| 2018 | 3.00x | CN¥1.64 Billion | CN¥545.78 Million | CN¥379.63 Million | ▲ +451.1% |
| 2017 | 0.54x | CN¥387.93 Million | CN¥712.27 Million | CN¥291.80 Million | ▼ -39.6% |
| 2016 | 0.90x | CN¥874.41 Million | CN¥969.71 Million | CN¥231.83 Million | ▼ -32.0% |
| 2015 | 1.33x | CN¥1.10 Billion | CN¥831.26 Million | CN¥286.97 Million | ▲ +90.7% |
| 2014 | 0.70x | CN¥429.23 Million | CN¥617.43 Million | CN¥429.23 Million | ▼ -65.7% |
| 2013 | 2.02x | CN¥476.32 Million | CN¥235.36 Million | CN¥476.32 Million | ▲ +107.4% |
| 2012 | 0.98x | CN¥239.76 Million | CN¥245.76 Million | CN¥239.76 Million | ▲ +38.1% |
| 2011 | 0.71x | CN¥133.09 Million | CN¥188.36 Million | CN¥133.09 Million | ▼ -21.3% |
| 2010 | 0.90x | CN¥113.07 Million | CN¥125.93 Million | CN¥113.07 Million | ▲ +158.3% |
| 2009 | 0.35x | CN¥53.32 Million | CN¥153.39 Million | CN¥53.32 Million | ▼ -57.8% |
| 2008 | 0.82x | CN¥81.12 Million | CN¥98.56 Million | CN¥81.12 Million | ▼ -19.5% |
| 2007 | 1.02x | CN¥81.83 Million | CN¥79.98 Million | CN¥81.83 Million | ▲ +10.9% |
| 2006 | 0.92x | CN¥65.67 Million | CN¥71.20 Million | CN¥65.67 Million | ▼ -6.9% |
| 2005 | 0.99x | CN¥116.57 Million | CN¥117.65 Million | CN¥116.57 Million | ▲ +1.7% |
| 2004 | 0.97x | CN¥63.81 Million | CN¥65.47 Million | CN¥63.81 Million | ▲ +61.0% |
| 2003 | 0.61x | CN¥40.34 Million | CN¥66.64 Million | CN¥40.34 Million | — |